Macrogenics (MGNX) Non-Current Assets (2012 - 2026)

Macrogenics (MGNX) reported Non-Current Assets of $35.4 million for Q1 2026, down 16.78% year-over-year from $42.5 million in Q1 2025, and down 4.21% quarter-over-quarter from $36.9 million in Q4 2025.

Macrogenics (MGNX) Non-Current Assets (2012 - 2026) Analysis & Trends

Macrogenics (MGNX) has 15 years of Non-Current Assets data on file, last reported at $35.4 million in Q1 2026.

  • Non-Current Assets for Q1 2026 came in at $35.4 million, down 16.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $151.4 million (down 12.55% YoY), and the FY2025 annual result was $36.9 million, down 16.44% from the prior year.
  • Non-Current Assets retreated to $35.4 million in Q1 2026 per MGNX's latest filing, from $36.9 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $58.3 million in Q4 2022 and troughed at $35.4 million in Q1 2026.
  • A 5-year average of $45.9 million and a median of $45.7 million in 2024 frame the typical range for Non-Current Assets.
  • The sharpest annual moves came in 2022 and 2023: Non-Current Assets advanced 4.67% in 2022, then fell 19.23% in 2023.
  • A 5-year view of Non-Current Assets shows it stood at $58.3 million in 2022, then slipped by 19.23% to $47.1 million in 2023, then retreated by 6.19% to $44.2 million in 2024, then decreased by 16.44% to $36.9 million in 2025, then decreased by 4.21% to $35.4 million in 2026.
  • Business Quant data shows MGNX's Non-Current Assets at $35.4 million in Q1 2026, $36.9 million in Q4 2025, and $38.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 62,953.78
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4.56 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 486.60 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 30.30 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 14.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - 39.71 Mn
10 Macrogenics 260.14 Mn 193.63 Mn - 35.35 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 35.35 Mn
Dec 31, 2025 36.91 Mn
Sep 30, 2025 38.67 Mn
Jun 30, 2025 40.47 Mn
Mar 31, 2025 42.48 Mn
Dec 31, 2024 44.17 Mn
Sep 30, 2024 42.30 Mn
Jun 30, 2024 44.19 Mn
Mar 31, 2024 45.71 Mn
Dec 31, 2023 47.08 Mn
Sep 30, 2023 48.65 Mn
Jun 30, 2023 50.98 Mn
Mar 31, 2023 54.56 Mn
Dec 31, 2022 58.29 Mn
Sep 30, 2022 47.54 Mn
Jun 30, 2022 50.41 Mn
Mar 31, 2022 53.24 Mn
Dec 31, 2021 55.69 Mn
Sep 30, 2021 57.46 Mn
Jun 30, 2021 58.92 Mn